Disease-modifying effects of metabolic perturbations in ALS/FTLD
Abstract Amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD) are two fatal neurodegenerative disorders with considerable clinical, pathological and genetic overlap. Both disorders are characterized by the accumulation of pathological protein aggregates that contain a num...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-12-01
|
Series: | Molecular Neurodegeneration |
Online Access: | http://link.springer.com/article/10.1186/s13024-018-0294-0 |